Background-Fibrotic and autonomic remodeling in heart failure (HF) increase vulnerability to atrial fibrillation (AF).
A trial fibrillation (AF) is a complex arrhythmia with a variety of underlying molecular and structural mechanisms contributing to a vulnerable AF substrate. 1, 2 The complexity of AF substrate seems to be reflected in the characteristics of AF electrograms (EGMs), with AF EGM morphology in paroxysmal AF being different than in more persistent AF. 3 However, the precise structural and functional mechanisms that lead to the formation of AF EGMs have not been well elucidated. The need for a better understanding of the mechanisms underlying AF EGM formation is heightened by several recent descriptions of regions of high-frequency activity during AF called complex fractionated atrial EGMs (CFAEs). 4 Several recent reports suggest that ablation of CFAEs seems to increase AF ablation success. 5 
Clinical Perspective on p 649
In the setting of structural heart disease, specifically heart failure (HF), a variety of mechanisms (eg, changes in ion-channel expression and gap junction distribution, inflammation, oxidative stress, and a variety of structural changes) are thought to contribute to the creation of a vulnerable AF substrate. 2 Of the structural changes that occur in the HF atrium, fibrosis is considered to be especially important in creating conditions conducive to the genesis and maintenance of AF. 2 In more structurally normal hearts, other mechanisms (eg, heightened autonomic activity 6 ) are thought to play a more dominant role in the genesis of AF. We, therefore, postulated that time and frequency domain characteristics of AF EGMs would be significantly different during AF recorded from a canine HF model of AF (a model that is known to harbor a large amount of fibrosis) 7 compared with AF induced in normal dogs with autonomic stimulation. We further hypothesized that the signal content AF EGMs in HF would be closely correlated with the extent and heterogeneity of fibrosis (and the related distribution of fat and myocardium). Specifically, we hypothesized that increasing fibrosis would correlate with slowing and disorganization of AF EGMs and that the spatial distribution (heterogeneity) of fibrosis would directly correlate with the spatial distribution of AF EGMs. Last, because autonomic remodeling is known to contribute at least partially to the creation of AF substrate in the setting of HF, 8 we hypothesized that the response to autonomic blockade of AF EGMs in the HF atrium would correspond to the underlying distribution of ganglion-rich fibrofatty tissue.
Methods
Detailed methods have been provided for each of the below sections in the online-only Data Supplement.
Experimental Protocol
Purpose-bred hound dogs (weight range, 25-35 kg) were used in the present study for both control and HF groups. This protocol conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (Publication No. 85-23, revised 1996) and was approved by the Animal Care and Use Committee of Northwestern University. Before undergoing the procedures listed below, all animals were premedicated with acepromazine (0.01-0.02 mg/kg) and were induced with propofol (3-7 mg/kg). All experiments were performed under general anesthesia (inhaled) with isoflurane (1%-3%). The adequacy of anesthesia was assessed by toe pinch and palpebral reflex.
Canine HF Model
In 21 dogs, HF was induced by 3 to 4 weeks of right ventricular tachypacing (240 beats per minute) by an implanted pacemaker. In 19 dogs, a transvenous pacemaker was placed via a jugular approach, under aseptic conditions. In 2 dogs, a pacemaker was placed on the ventricle via an epicardial approach (ie, via a left lateral thoracotomy). Left ventricular function was assessed during pacing by serial echocardiograms 8 (online-only Data Supplement Figure I ). HF was confirmed after 3 to 4 weeks of pacing. 8 Twenty dogs without rapid ventricular pacing were used as controls.
Open-Chest Mapping
At the terminal study, a left lateral thoracotomy was performed. Low-density and high-density mapping protocols were used. See the online-only Data Supplement for detailed methods for this section.
AF Induction
See the online-only Data Supplement for detailed methods for this section.
Histology
The histologic analysis described below (eg, comparison of tissue make-up between posterior left atrium [PLA] and left atrial appendage [LAA] ) and the EGM-tissue analysis were only performed for HF atria, as these atria are known to harbor significant fibrosis. Normal atria, however, are not known to have significant fibrosis. The online-only Data Supplement Figure II shows examples of histology from the PLA and LAA of 2 normal dogs; as shown, there is significantly less fibrosis (blue stain) in normal hearts compared with HF hearts (see Results). See the online-only Data Supplement for detailed methods for this section.
EGM Analysis
Custom analysis tools developed in MATLAB (Mathwork, Natick, MA) were used for all offline EGM analysis. The signals were divided into 4-second segments to account for any variability of both the signals and the measurements of the signals. We have previously shown that dominant frequencies (DFs) averaged from multiple 4-second segments were a better reflection of activation rates than single segments of any length. 9, 10 The following 4 measurements were computed: DF; organization index (OI); fractionation interval (FI); and Shannon entropy (ShEn). See the online-only Data Supplement for detailed methods for this section.
Tissue Analysis
Tissue and EGM Correlation
Each tissue section was divided into 4 quadrants. The high-density recordings, after being aligned to underlying tissue orientation, were also divided into 4 quadrants (see schematic in Figure 1B) . In each quadrant, the absolute amount of fat, fibrosis, and myocardium was assessed. Linear regression analysis was performed to assess the correlation between tissue and EGM characteristics.
Statistical Methods
All data are reported as mean±SE. Mixed effects ANOVA was used to compare the mean DF, OI, FI, and ShEn between HF and normal dogs and among pulmonary vein (PV), PLA, and LAA. SDs to quantify spatial heterogeneity were also analyzed in a similar fashion. In the HF dogs that underwent high-density mapping, comparison of EGMs between the PLA and LAA were made using unpaired t tests (as these regions were mapped at separate times during the electrophysiological study [ie, not simultaneously as was the case with low-density mapping]). Comparisons of tissue characteristics between the PLA and LAA were made using paired t tests. Before and after comparisons made in the same animals (eg, before and after double autonomic blockade) were assessed for significant differences via paired t tests.
Tissue and EGM correlations were performed by dividing each tissue section into 4 quadrants paired with the EGM characteristics (DF, OI, FI, and ShEn) of the high-density maps similarly divided into 4 quadrants and performing linear regression analysis. P≤0.05 was taken as significant for all the above analyses.
Results

AF EGMs in HF Versus Normal Left Atrium
Dominant Frequency
Mixed effect ANOVA showed significantly lower mean DFs with HF than in normals (P=0.0002), but no significant difference in mean DF between sites (P=0.65; Figure 2A ). Heterogeneity (SD) of DF was also lower in HF than in normals, but with significant regional differences (ie, dispersion) within the left atrium (P=0.0007; Figure 2B ). SD of DF for normals was significantly higher in PV than in the PLA and LAA (P<0.01), whereas SD of DF of the PV and PLA were significantly higher than the LAA with HF (P<0.02).
Organization Index
Mean OI was significantly higher in HF dogs than in normals (P=0.0001), with significant regional differences within the left atrium (P=0.0002; Figure 2C ). For normal dogs, the OIs were lower in the PLA than in the LAA (P<0.03). For HF dogs, the OIs were lower in the PV and PLA than in the LAA (P<0.04). SD of OI was not different between HF and normals (P=0.59) but showed regional differences within the left atrium ( Figure 2D ). SD of OI was significantly higher in the PLA than in the LAA (P<0.002).
Fractionation Interval
Mean FI was significantly higher in HF dogs than in normals (P<0.0001), with significant regional differences within the left atrium (P=0.003; Figure 2E ). For normal dogs, the FIs were significantly lower in the PV and PLA than in the LAA (P<0.03). SD of OI was significantly lower in the HF dogs than in the normal dogs (P<0.0001) but showed no significant regional differences within the left atrium ( Figure 2F ).
Percentage of CFAEs
Percentage CFAE was significantly lower in HF than in normals in the PV (72±4 versus 88±4%; P=0.002), PLA (59±4 versus 92±2%; P<0.001), and LAA (59±5 versus 80±6%; P=0.003). In HF, %CFAE was significantly greater in the PV than in the PLA or LAA (P<0.05, for both comparisons). In normals, %CFAEs were significantly greater in the PLA and PV than in the LAA (P<0.05, for both comparisons).
Shannon Entropy
Mean ShEn trended lower in HF dogs than in normals (P<0.08), with significant regional differences within the left atrium (P=0.003; Figure 2G ). For HF dogs, ShEn levels were significantly higher in the PV and PLA than that in the LAA (P<0.0006). SD of ShEn was not different between HF dogs and normal dogs (P=0.14) or between sites (P=0.31; Figure 2H ).
AF EGM Characteristics in the HF PLA Versus LAA (With High-Density Plaques)
In both the PLA and LAA, there was no difference in DF between low-and high-density plaques (online-only Data Supplement Figure III ). However, OI was lower, FI was greater, and ShEn was lower with high-density plaques compared with the low-density plaques (online-only Data Supplement Figure  III ). This is likely because of the difference in interelectrode distance between the plaques; as shown in the online-only Data Supplement Figure IV , increasing interelectrode distance for the same set of bipolar recordings results in a decrease in OI, decrease in FI, and increase in ShEn. All the remaining AF mapping data below was obtained with high-density plaques. In the 1 dog that underwent both low-and high-density mapping, the differences between low-and high-density mapping were consistent with the overall mean differences for all dogs between low-versus high-density mapping (online-only Data Supplement Table I) .
Overall, differences between the PLA and LAA during high-density mapping (where the PLA and LAA were mapped sequentially) were similar to those found during lowdensity mapping (where the PV, PLA, and LAA were mapped simultaneously). OI was significantly lower in the HF PLA compared with the LAA, with ShEn trending toward being greater in the PLA than in the LAA ( Figure 3A) . DF, OI, FI, and ShEn were all more heterogeneous in the HF PLA than the LAA ( Figure 3B ).
Distribution of Fibrosis, Fat, and Nerves in the HF Left Atrium
The PLA had significantly more fat than the LAA (36.4±2.8% versus 21.6±2.2%; P<0.001) ( Figure 4A , subpanel i). Percentage myocardium was greater in the LAA than in the PLA (53.5±2.4% versus 35.6%±2.9%; P<0.001). There was no significant difference in fibrosis between the PLA and LAA. Percentage fat was assessed in the PLA in a small number of normal dogs (n=3) and was found to be no different than in HF (36.4±2.8% versus 30.1±2.1%; P=0. 22) .
Myocardium and fibrosis were more heterogeneously distributed in the PLA than in the LAA (SD of %myocardium in PLA versus LAA=20.5±1.7% versus 14.1±1.3%; P=0.01; SD of %fibrosis in PLA versus LAA=16.9±1.9% versus 12.3±1.5%; P=0.02; Figure 4A , subpanel ii). Fat also trended toward being more heterogeneous in the PLA than in the LAA (17.3±1.7% versus 12.3±2.3%; P=0.07). Figure 4B shows examples of significantly greater fat in the PLA (subpanels i and iii) than the LAA (subpanels ii and iv). These panels also demonstrate that fat, fibrosis, and myocardium were more heterogeneously distributed in the PLA than in the LAA. A significant number of nerve trunks were noted in the PLA fat (43±9; Figure 4B , subpanel i, and Figure 5C for examples of nerve trunks/bundles in the PLA). In contrast, no nerve trunks were found in the LAA.
Correlation Between AF EGM Characteristics and Fibrosis
DF was negatively correlated to %fibrosis (r=−0.45; P=0.006; Figure 6A , subpanel i), whereas FI was positively correlated with %fibrosis (r=0.42; P=0.01; Figure 6A , subpanel ii) in the PLA. Heterogeneity (SD) of DF and heterogeneity (SD) of FI were correlated with heterogeneity (SD) of fibrosis (for DF, r=0.41; P=0.01; for FI, r=0.47; P=0.004; Figure 6B , subpanels i and ii, respectively). Figure 7A shows an example of OI being lower and more heterogenous (ie, greater SD) in the HF PLA than the LAA. Figure 7B shows an example of DF being more heterogeneous in the HF PLA compared with the LAA. Subpanels i and ii in each panel show the Masson-Trichrome stained PLA and LAA, respectively. Subpanels iii and iv in Figure 7A show the corresponding OI maps for each region mapped. Similarly, subpanels iii and iv in Figure 7B show the corresponding DF maps for each region mapped.
Effect of Double Autonomic Blockade on EGM Content in the HF Left Atrium
In the PLA, double autonomic blockade lead to a significant decrease in DF (from 6.8±0.6 to 6.1±0.7 Hz; P<0.001) and an increase in FI (from 138±18 to 158±26 ms; P=0.002; Figure 5A ). The increase in FI by double autonomic blockade was paralleled by a decrease in %CFAEs in the PLA (from 34±15% to 21±13%; P=0.01). A trend toward the decrease of ShEn was noted in PLA in the presence of double autonomic blockade (from 0.76±0.01 to 0.73±0.01; P=0.098). No change in OI was noted in the PLA with double autonomic blockade. In the LAA, there was no change in any of these measures in the presence of double autonomic blockade ( Figure 5A ). Figure 5B shows examples of EGMs before and after autonomic blockade; as shown, the AF EGMs become significantly slower and less fractionated after autonomic blockade. Figure 5C shows that with autonomic blockade, DF changes significantly over regions of fat in the PLA. In Figure 5C , subpanel i shows the PLA being mapped. Subpanels ii and iii show the DF map before and after autonomic blockade; as shown, there is a significant decrease in DF after autonomic blockade. Moreover, the decrease in DF is most pronounced over regions of fat that contain large nerve trunks (encircled regions). Subpanel iv highlights a large nerve trunk seen in subpanel i. In the PLA, change in ShEn (∆ShEn) with autonomic blockade was positively correlated with %fatty tissue (r=0.42; P<0.05; Figure 6C ). A, subpanel ii, Heterogeneity of fat, fibrosis, and myocardium in the PLA and LAA of HF dogs. B, subpanels i-iv, Individual sections (×4) from the PLA (subpanels i and iii) and LAA (subpanels ii and iv), respectively, highlighting that (1) there is significantly more fat in the PLA than the LAA and (2) fibrosis, fat, and myocardium are all more heterogeneously distributed in the PLA than the LAA. In addition, subpanel i demonstrates a typical nerve trunk in the PLA. NS indicates nonsignificant. 
Discussion
In the present study, we have systematically assessed the correlation between AF EGM characteristics and the underlying quantity and distribution of fibrosis. Using a variety of time and frequency domain measures, we examined the signal characteristics of AF EGMs in the setting of HF (where fibrosis is known to be a key contributor to the genesis and maintenance of AF) and compared these with AF EGMs in normal hearts (where AF was induced by vagal stimulation). We also systematically assessed the relationship between the characteristics of AF EGMs in HF and the underlying distribution of myocardium, fibrosis, fat, and autonomic ganglia in the failing left atrium. Our findings are summarized as follows: (1) AF EGM measures are significantly different in AF in the normal versus the HF atrium, with AF being slower (lower DF), more organized (higher OI), and having a higher FI in the setting of HF; (2) there are significant regional differences in AF signal content in HF, with AF being less organized (lower OI) in the PLA than in the LAA; moreover, all EGM measures are significantly more spatially heterogeneous in the PLA than in the LAA; (3) there is a significantly greater amount of fat in the PLA compared with the LAA, with the fat being richly innervated with large nerve trunks; moreover, fibrofatty tissue is more heterogeneously distributed in the 
Differences in AF EGM Characteristics in HF Versus Normal Heart: Contribution of Fibrosis to AF EGMs
Although animal and clinical studies strongly suggest that fibrosis and other structural changes in the myocardium contribute to substrate for sustained AF, 2 the precise contribution of fibrosis to EGM characteristics in AF is not well characterized. However, recent studies do suggest that there are differences in the distribution and characteristics of CFAEs in paroxysmal and permanent AF. 3, 11 These differences may at least be, in part, because of the heterogeneity of underlying structural substrate in these patients, with atria in persistent AF being more likely to harbor fibrotic changes. 12 It is known that slow or heterogeneous conduction 13, 14 can lead to the formation of fractionated EGMs (eg, as seen in infarcts after a period of healing), 14 with electrical uncoupling of fibers occurring at the microscopic level resulting in complex pathways and zigzag propagation. A similar scenario may occur in the presence of fibrous tissue. 15 In the present study, we have attempted to systematically characterize AF EGMs in 2 well-characterized substrates for AF: that is, (1) in a normal heart where vagal stimulation (with resulting refractory period shortening) is the primary mechanism for AF and (2) in pacing-induced HF where fibrosis is thought to be a dominant mechanism underlying AF, 7 with other mechanisms, such as oxidative stress 16 and autonomic dysfunction, 8 also contributing at least partially to AF substrate. We discovered that AF EGM content is significantly different in normal versus HF atria, with EGMs in HF being significantly slower, and contrary to our initial hypothesis, more organized and less fractionated compared with AF EGMs in normal hearts. The strong correlation between the amount and heterogeneity of fibrosis and the time and frequency domain measures of AF EGMs in HF suggests that fibrosis may contribute at least partially to AF EGM characteristics. These findings also suggest that in patients with AF, worsening structural heart disease may be contributing not only to the increasing chronicity of AF but also to AF EGM content. Although these findings may seem contradictory to clinical data that shows that CFAE% are higher in patients with persistent than paroxysmal AF, 17 it must be remembered that the precise structural substrate underlying AF EGMs (and the specific contribution of fibrosis to AF EGMs) was not characterized in these prior studies. Indeed, the observation by Xi et al 18 that f-wave frequency of AF on surface ECGs is known to decrease with increasing age further supports the notion that increasing atrial fibrosis, which is well known to occur in the aging heart, may also be contributing to a slowing and organization of AF in the failing atrium. A possible explanation for our findings may also be the fact that the dogs we studied had fairly advanced HF and a large amount of fibrosis. It is tempting to speculate that lesser degrees of interstitial fibrosis between healthy myocytes (eg, in early-stage HF) may be more likely to set up microscopic conduction barriers (and resulting anisotropy) that may be conducive to the creation of disorganized EGMs. However, increasing fibrosis and an accompanying reduction in viable myocardium, as may be seen in advanced HF, may lead to the coalescing and organizing of activation wavefronts in the atrium, with an increased organization of AF EGMs. In addition, pacing-induced HF is known to lead to prolongation of atrial refractoriness 19 ; an increase in the atrial effective refractory period causes an increase in AF wavelength and may, therefore, lead to an increase in the AF cycle length and organization. Further studies need to be done to assess the effect of the severity/stage of HF on AF EGM organization. Another possible explanation for the differences observed in the HF dogs versus normal dogs is that, in the latter, AF was induced by vagal stimulation. Because true vagal AF is seen only in a minority of patients with paroxysmal AF, the normal AF characteristics that we demonstrate in our canine model may not be representative of all patients with paroxysmal AF.
Therefore, it seems that EGM differences between HF and normal hearts may provide valuable insight into the pathophysiologic mechanisms underlying AF and may be of potential clinical significance in patients with AF undergoing AF ablation. It is well known that success rates of ablation procedures decrease in patients with permanent AF (compared with paroxysmal AF), at least, in part, because of the presence of structural heart disease in these patients. 20 However, the addition of EGM-guided ablation (eg, CFAE ablation) seems to increase long-term success of these procedures. 21 Nonetheless, despite the success of CFAE-guided ablation in decreasing AF recurrence in some series, it is well recognized that not all CFAEs contribute to the formation of AF substrate. A better understanding of EGM signal content and how it relates to the underlying areas of fibrosis may, therefore, help refine current, EGM-based ablation techniques. For example, based on the findings of the present study, the increased regularity of EGMs (indicated by increased OI in HF) in the presence of slower activation rates (indicated by lower DFs and higher FIs) in HF may indicate the presence of regions of underlying fibrosis. It is tempting to speculate that an enhanced ability to identify islands dense fibrosis (by real-time AF EGM analysis) may in turn allow for a greater precision in the placement of linear ablation lesions in the atrium.
Contribution of the Autonomic Nervous System to AF EGMs in the HF Left Atrium
Recent data suggests that at least some left atrial CFAEs may be located in the anatomic vicinity of autonomic ganglionated plexi. 22, 23 Other data indicate that heightened vagal activity may contribute to the formation of CFAE-like EGMs. 22, 24 More recently, Habel et al 25 showed that CFAEs organize and DF decreases in the atrium in response to autonomic blockade. Knecht et al 26 also showed that CFAEs organize in response to autonomic blockade, with organization being noted in patients with paroxysmal but not persistent AF. To our knowledge though, the effect of autonomic blockade on AF in the setting of HF has not been well studied. Based on the findings of Knecht et al, 26 one would suspect that in the presence of structural heart disease, which is more likely to cause persistent AF, there would be little autonomic contribution to AF EGMs. However, our data clearly demonstrate a decrease in DF and increase in FI in the failing PLA in the presence of autonomic blockade. The present study also demonstrates that autonomic changes in EGM content correlate with the underlying distribution of nerve-rich fibrofatty tissue in the PLA. These diverging results may be partially explained by species differences between persistent human AF and AF in a canine model. Nonetheless, the findings of the present study are consistent with recent studies that support a role for the autonomic nervous system in contributing to AF substrate in the HF setting.
8,27,28 Indeed, both the sympathetic and the parasympathetic nervous system seem to be contributing to AF substrate in HF 8 ; in that study, it was reported that in spite of the vagal hyperinnervation noted in the HF left atrium, there is a decrease in vagal responsiveness in the HF atria because of a compensatory increase in acetycholinestrase activity. It is possible that this increase in acetycholinestrase activity may be contributing at least partially to the differences noted in AF EGM characteristics in HF AF versus AF induced by vagal stimulation in normal dogs. The enhanced autonomic responsiveness of AF EGMs in the PLA (compared with the LAA) also supports our recent findings where autonomic remodeling in the HF atrium, both at the structural and functional levels, is significantly more pronounced in the PLA than in the rest of the left atrium. 8 Taken together, the clear contribution of fatty tissue harboring large autonomic nerve trunks to time and frequency domain measures of EGM characteristics suggests that a detailed assessment of AF EGM content in the present of autonomic blockade may help better target autonomic ganglia during ablation.
Study Limitations
This was an animal study; our results in normal canine hearts (ie, vagal-induced AF) and in the setting of pacing-induced HF cannot, therefore, be directly extrapolated to human AF, both for normal and diseased hearts. Moreover, detailed EGM-tissue correlations were performed only in HF atria and not in normal atria. Also, AF is a multifactorial disease, and a variety of mechanisms contribute to the creation of AF substrate; in this study, we only examined the contribution of fibrosis and the autonomic nervous system to AF EGM content. Future studies are needed to investigate the contribution of other mechanisms on EGM formation in the HF atrium (eg, fiber orientation, gap junction expression, and oxidative stress).
Last, the correlation between fibrosis distribution and AF EGM content does not necessarily imply a causal role for fibrosis in CFAE formation. Further studies are necessary to fully understand how fibrosis contributes to EGM characteristics in AF, both in normal hearts and in the setting of HF.
Because we mapped the epicardium, we only assessed histology from the epicardial aspect of the left atrium. However, because of transmural differences in electrophysiological characteristics in the atrial wall, 29 characteristics of AF EGMs mapped epicardially cannot be directly extrapolated to the endocardium. Further studies are needed to assess the impact of transmural tissue characteristics on AF EGMs.
Even though we performed double autonomic blockade in HF, we did not perform parasympathetic blockade alone versus sympathetic blockade alone to study the specific effects of sympathetic versus parasympathetic signaling on AF EGMs in HF.
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